• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环钙磷复合物中无定形磷酸钙比值与血液透析患者预后生物标志物的关系。

Association between amorphous calcium-phosphate ratios in circulating calciprotein particles and prognostic biomarkers in hemodialysis patients.

机构信息

Department of Urology, Graduate School of Medicine, Yamaguchi University, 1‑1‑1, Minamikogushi, Ube, Yamaguchi, 755-8505, Japan.

Division of Anti-Aging Medicine, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.

出版信息

Sci Rep. 2022 Jul 29;12(1):13030. doi: 10.1038/s41598-022-17405-7.

DOI:10.1038/s41598-022-17405-7
PMID:35906396
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9338083/
Abstract

Calciprotein particles (CPPs) are circulating colloidal mineral-protein complexes containing crystalline and/or non-crystalline (amorphous) calcium-phosphate (CaPi). Serum CPP levels correlate with vascular stiffness and calcification in patients with chronic kidney disease (CKD). In vitro studies showed that CPPs containing crystalline CaPi were more arteriosclerogenic and inflammogenic than CPPs without containing crystalline CaPi. Thus, we hypothesized that not only the quantity but also the quality of CPPs (the phase of CaPi) might affect clinical outcomes. To test this hypothesis, we quantified amorphous CaPi ratio defined as the ratio of the amorphous CaPi amount to the total CaPi amount in serum CPPs from 183 hemodialysis patients and explored its possible correlation with serum parameters associated with prognosis of hemodialysis patients. Multivariate analysis revealed that the amorphous CaPi ratio correlated positively with hemoglobin and negatively with fibroblast growth factor-21 (FGF21), which remained significant after adjusting for the total CaPi amount. Because low hemoglobin and high FGF21 are associated with increased mortality, the present study warrants further studies to determine whether low amorphous CaPi ratio in circulating CPPs may be associated with poor prognosis in hemodialysis patients.

摘要

钙磷蛋白颗粒 (CPPs) 是循环胶体矿物-蛋白复合物,含有结晶和/或非晶(无定形)的钙磷 (CaPi)。血清 CPP 水平与慢性肾脏病 (CKD) 患者的血管僵硬和钙化相关。体外研究表明,含有结晶 CaPi 的 CPP 比不含结晶 CaPi 的 CPP 更具有动脉粥样硬化和促炎作用。因此,我们假设 CPP 的质量(CaPi 的相)不仅会影响临床结果,而且 CPP 的数量也会影响。为了验证这一假设,我们从 183 名血液透析患者的血清 CPP 中定量了无定形 CaPi 比例(定义为无定形 CaPi 量与总 CaPi 量的比值),并探讨了其与与血液透析患者预后相关的血清参数的可能相关性。多变量分析显示,无定形 CaPi 比例与血红蛋白呈正相关,与成纤维细胞生长因子-21(FGF21)呈负相关,在调整总 CaPi 量后仍具有显著相关性。由于低血红蛋白和高 FGF21 与死亡率增加相关,因此本研究需要进一步研究以确定循环 CPPs 中低无定形 CaPi 比例是否与血液透析患者的预后不良相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a28/9338083/fc95df36bb33/41598_2022_17405_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a28/9338083/c80b271b66e5/41598_2022_17405_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a28/9338083/fc95df36bb33/41598_2022_17405_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a28/9338083/c80b271b66e5/41598_2022_17405_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a28/9338083/fc95df36bb33/41598_2022_17405_Fig2_HTML.jpg

相似文献

1
Association between amorphous calcium-phosphate ratios in circulating calciprotein particles and prognostic biomarkers in hemodialysis patients.循环钙磷复合物中无定形磷酸钙比值与血液透析患者预后生物标志物的关系。
Sci Rep. 2022 Jul 29;12(1):13030. doi: 10.1038/s41598-022-17405-7.
2
Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.使用荧光双膦酸盐定量血清/血浆样本中的钙磷蛋白颗粒 (CPPs)。
Methods Mol Biol. 2023;2664:333-341. doi: 10.1007/978-1-0716-3179-9_21.
3
Removal of calciprotein particles from the blood using an adsorption column improves prognosis of hemodialysis miniature pigs.使用吸附柱从血液中去除钙磷复合物颗粒可改善血液透析小型猪的预后。
Sci Rep. 2023 Sep 12;13(1):15026. doi: 10.1038/s41598-023-42273-0.
4
The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients.不同胶体特性 CPP 在血液透析患者中对炎症反应的影响。
Sci Rep. 2022 Dec 17;12(1):21856. doi: 10.1038/s41598-022-26166-2.
5
Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.肝脏和脾脏在慢性肾脏病大鼠模型中主要介导钙磷蛋白颗粒清除。
Am J Physiol Renal Physiol. 2024 Apr 1;326(4):F622-F634. doi: 10.1152/ajprenal.00239.2023. Epub 2024 Feb 29.
6
Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).慢性肾脏病循环钙磷蛋白颗粒和细胞外囊泡促进血管钙化:GRP(富含 Gla 蛋白)的作用。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):575-587. doi: 10.1161/ATVBAHA.117.310578. Epub 2018 Jan 4.
7
Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.蔗糖铁氧羟化物对透析患者内源性钙磷复合物、炎症和血管细胞的影响。
Nephrol Dial Transplant. 2023 May 4;38(5):1282-1296. doi: 10.1093/ndt/gfac271.
8
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.基于凝胶过滤法的维持性血液透析患者钙磷颗粒的中期预测价值。
Atherosclerosis. 2020 Jun;303:46-52. doi: 10.1016/j.atherosclerosis.2020.03.016. Epub 2020 Mar 21.
9
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.钙磷微晶病症作为慢性肾脏病进展的范例。
Curr Opin Nephrol Hypertens. 2023 Jul 1;32(4):344-351. doi: 10.1097/MNH.0000000000000890. Epub 2023 Apr 19.
10
Novel assessments of systemic calcification propensity.系统性钙化倾向的新型评估方法。
Curr Opin Nephrol Hypertens. 2016 Jul;25(4):278-84. doi: 10.1097/MNH.0000000000000237.

引用本文的文献

1
The formation and function of calciprotein particles.钙蛋白颗粒的形成与功能。
Pflugers Arch. 2025 Jun;477(6):753-772. doi: 10.1007/s00424-025-03083-7. Epub 2025 Apr 23.
2
Size-dependent interactions between calciprotein particles and vascular endothelium.钙蛋白颗粒与血管内皮之间的尺寸依赖性相互作用。
Mater Today Bio. 2025 Feb 19;31:101599. doi: 10.1016/j.mtbio.2025.101599. eCollection 2025 Apr.
3
The Bone-Vascular Axis: A Key Player in Chronic Kidney Disease Associated Vascular Calcification.骨-血管轴:慢性肾脏病相关血管钙化的关键因素

本文引用的文献

1
Klotho and calciprotein particles as therapeutic targets against accelerated ageing.Klotho 和钙磷蛋白颗粒作为对抗加速衰老的治疗靶点。
Clin Sci (Lond). 2021 Aug 13;135(15):1915-1927. doi: 10.1042/CS20201453.
2
Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.肾管状液中的磷酸钙微晶加速慢性肾病进展。
J Clin Invest. 2021 Aug 16;131(16). doi: 10.1172/JCI145693.
3
Mud in the blood: the role of protein-mineral complexes and extracellular vesicles in biomineralisation and calcification.
Kidney Dis (Basel). 2024 Sep 6;10(6):545-557. doi: 10.1159/000541280. eCollection 2024 Dec.
4
Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis.接受常规和非工作时间血液透析患者中钙磷蛋白颗粒与血清磷的关联
Clin Kidney J. 2024 May 6;17(6):sfae121. doi: 10.1093/ckj/sfae121. eCollection 2024 Jun.
5
Vitamin D: A Bridge between Kidney and Heart.维生素D:肾脏与心脏之间的桥梁。
Life (Basel). 2024 May 10;14(5):617. doi: 10.3390/life14050617.
6
Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview.慢性肾脏病合并矿物质与骨异常及血管钙化:概述
Life (Basel). 2024 Mar 21;14(3):418. doi: 10.3390/life14030418.
7
Small organic molecules containing amorphous calcium phosphate: synthesis, characterization and transformation.含无定形磷酸钙的有机小分子:合成、表征及转化
Front Bioeng Biotechnol. 2024 Jan 12;11:1329752. doi: 10.3389/fbioe.2023.1329752. eCollection 2023.
8
Calciprotein Particles Induce Cellular Compartment-Specific Proteome Alterations in Human Arterial Endothelial Cells.钙蛋白颗粒诱导人动脉内皮细胞中特定细胞区室的蛋白质组改变。
J Cardiovasc Dev Dis. 2023 Dec 22;11(1):5. doi: 10.3390/jcdd11010005.
9
Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease-Mineral and Bone Disorder in Non-Dialysis Adult Patients.非透析成年患者慢性肾脏病 - 矿物质和骨异常诊断与管理中使用的当前及新出现的标志物和工具
J Clin Med. 2023 Sep 30;12(19):6306. doi: 10.3390/jcm12196306.
血液中的泥:蛋白质-矿物质复合物和细胞外囊泡在生物矿化和钙化中的作用。
J Struct Biol. 2020 Oct 1;212(1):107577. doi: 10.1016/j.jsb.2020.107577. Epub 2020 Jul 22.
4
The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review.慢性肾脏病贫血对患者的影响:发病率、危险因素及临床结局——一项系统文献综述
Int J Nephrol. 2020 Jul 1;2020:7692376. doi: 10.1155/2020/7692376. eCollection 2020.
5
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay.基于凝胶过滤法的维持性血液透析患者钙磷颗粒的中期预测价值。
Atherosclerosis. 2020 Jun;303:46-52. doi: 10.1016/j.atherosclerosis.2020.03.016. Epub 2020 Mar 21.
6
Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts.钙蛋白颗粒调节成骨细胞中纤维母细胞生长因子-23的表达。
Kidney Int. 2020 Apr;97(4):702-712. doi: 10.1016/j.kint.2019.10.019. Epub 2019 Nov 9.
7
Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation.慢性肾脏病中成纤维细胞生长因子 21 的增加是生存获益与血压失调之间的权衡。
Sci Rep. 2019 Dec 17;9(1):19247. doi: 10.1038/s41598-019-55643-4.
8
Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?Klotho 和内分泌成纤维细胞生长因子:慢性肾脏病进展和心血管并发症的标志物?
Nephrol Dial Transplant. 2019 Jan 1;34(1):15-21. doi: 10.1093/ndt/gfy126.
9
Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.鉴定和量化慢性肾脏病患者血浆中具有不同物理特性的钙磷复合物颗粒。
Sci Rep. 2018 Jan 19;8(1):1256. doi: 10.1038/s41598-018-19677-4.
10
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.循环成纤维细胞生长因子21与终末期肾病死亡率之间的关联。
PLoS One. 2017 Jun 5;12(6):e0178971. doi: 10.1371/journal.pone.0178971. eCollection 2017.